331 related articles for article (PubMed ID: 8084981)
1. Efficacy of treatment for geropsychiatric patients with severe mental illness.
Schneider LS
Psychopharmacol Bull; 1993; 29(4):501-24. PubMed ID: 8084981
[TBL] [Abstract][Full Text] [Related]
2. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
3. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
4. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
5. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
6. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions.
Wragg RE; Jeste DV
Psychiatr Clin North Am; 1988 Mar; 11(1):195-213. PubMed ID: 2898133
[TBL] [Abstract][Full Text] [Related]
10. Behavioral complications and their treatment in Alzheimer's disease.
Devanand DP
Geriatrics; 1997 Sep; 52 Suppl 2():S37-9. PubMed ID: 9307585
[TBL] [Abstract][Full Text] [Related]
11. Current status of family intervention science.
Diamond G; Siqueland L
Child Adolesc Psychiatr Clin N Am; 2001 Jul; 10(3):641-61. PubMed ID: 11449817
[TBL] [Abstract][Full Text] [Related]
12. [Depression and frontal dysfunction: risks for the elderly?].
Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
[TBL] [Abstract][Full Text] [Related]
13. ["Judicious" use of neuroleptic drugs in the treatment of behavioral symptoms in the course of Alzheimer disease].
Riva E; Nobili A; Trecate F
Recenti Prog Med; 1998 Nov; 89(11):598-603. PubMed ID: 9844448
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial treatments for bipolar disorders.
Scott J; Colom F
Psychiatr Clin North Am; 2005 Jun; 28(2):371-84. PubMed ID: 15826737
[TBL] [Abstract][Full Text] [Related]
15. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
[TBL] [Abstract][Full Text] [Related]
16. Psychotic symptoms in the elderly--assessment and management.
O'Connor D
Aust Fam Physician; 2006 Mar; 35(3):106-8. PubMed ID: 16525519
[TBL] [Abstract][Full Text] [Related]
17. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
18. Treatment of depression--newer pharmacotherapies.
Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
[TBL] [Abstract][Full Text] [Related]
19. Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia.
Schneider LS; Sobin PB
Psychopharmacol Bull; 1992; 28(1):71-9. PubMed ID: 1351687
[TBL] [Abstract][Full Text] [Related]
20. Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics.
Lemke MR
J Clin Psychiatry; 1995 Aug; 56(8):354-7. PubMed ID: 7635851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]